U tijeku je upis prve generacije polaznika Sveučilišnog poslijediplomskog specijalističkog studija “Internistička onkologija” .
Stručni studij
HLZ- ESMO RSS
- EMA Recommends Extension of Indications for Trastuzumab Deruxtecan to Include Treatment for HER2-ultralow Breast Cancer 21. ožujka 2025.
- European Lung Cancer Congress 2025, Paris, France, 26-29 March 2025 20. ožujka 2025.
- FDA Approves Mirdametinib for Adult and Paediatric Patients with NF1 Who Have Symptomatic Plexiform Neurofibromas Not Amenable to Complete Resection 20. ožujka 2025.
- Real-World Patients with Cancer Show Lower Survival Times and Treatment-Associated Survival Benefits Compared to Those Included in RCTs 18. ožujka 2025.
- Patients with Breast, Colorectal, and Pancreatic Cancers With ATM, CHEK2, or PALB2 PVs Have Similar Mortality to the Average Genetically Tested Patients 18. ožujka 2025.
